Yale Cancer Center was awarded a SPORE grant for translational research in lung cancer
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
On Feb. 27, 2015, the U.S. Centers for Disease Control and Prevention (CDC) responded to the West Africa…
On Dec. 23, 2014, the U.S. Food and Drug Administration (FDA) approved a formulation of Novo Nordisk’s diabetes drug, liraglutide,…
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
On Dec. 18, 2014, the University of Nebraska Medical Center announced it had received a $1.3 million gift…
On Dec. 11, 2014, Dr. Andras Nagy, from the University of Toronto and leader of Project Grandiose, announced…
On Dec. 12, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
On Dec. 9, 2014, the Biotechnology Industry Organization (BIO) announced that Debbie Yaver, Novozymes’ director of expression technology,…
On Dec. 8, 2014, philanthropist and entrepreneur Paul G. Allen announced a commitment of $100 million to create…
On Dec. 3, 2014, the Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center…
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
On Nov. 27, 2014, two papers were published in Science that announced the completion and preliminary analyses of…
On Nov. 21, 2014, funding was announced for the TEC Health Accelerator for Alberta, to assist promising startup…
On Nov. 5, 2014, the Ford Family Foundation announced a $5 million grant to the Knight Cancer Institute…
On Oct. 23, 2014, philanthropist Paul G. Allen donated $100 million to fight Ebola and called on the…
On Oct. 21, 2014, the Jackson Laboratory (JAX) announced that technology investor David Roux and his wife Barbara…
On Oct. 20, 2014, Oregon Health & Science University’s Vaccine & Gene Therapy Institute (OHSU) announced it was…
On Oct. 15, 2014, Genentech drug Esbriet (pirfenidone) was approved by the U.S. Food and Drug Administration (FDA)…
On Oct. 15, 2014, the University of Iowa ushered in a new age of accelerated research in biomedicine…
On Oct. 13, 2014, the University of Minnesota’s Children’s Hospital was renamed the University of Minnesota Masonic Children’s…
On Oct. 9, 2014, a landmark study led by Douglas Melton from Harvard University successfully generated functional, mature human…
On Oct. 7, 2014, The Jackson Laboratory opened a state-of-the-art genomics research center on the campus of the…
On Oct. 3, 2014, the University of Gothenburg announced that seven Swedish women in a ground-breaking research project…
On Oct. 3, 2014, Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at the University…
On Sept. 30, 2014, Dole Food chairman and owner David Murdock announced he wants to take his vision…
On Sept. 30, 2014, the Centers for Disease Control and Prevention confirmed that Eric Duncan, a Liberian national…
On Sept. 19, 2014, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Sept. 12, 2014, the University of Iowa announced that alumnus Franklin D. Trueblood’s lifelong interest in medical…
On Sept. 10, 2014, an international team of scientists from Singapore, Thailand, China and Australia announced that they…